Status:

NOT_YET_RECRUITING

Integrating U=U Into HIV Counseling in South Africa (INTUIT-2.0)

Lead Sponsor:

Boston University

Collaborating Sponsors:

National Institute of Mental Health (NIMH)

Conditions:

HIV

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Undetectable = Untransmittable (U=U) is the scientific consensus that people with human immunodeficiency virus (HIV) who achieve viral suppression through antiretroviral treatment (ART) cannot transmi...

Detailed Description

The study will be a cluster-randomized trial (CRT), where clinics are pair-matched and randomized into immediate intervention (Group A) and deferred intervention (Group B, control) groups. The rationa...

Eligibility Criteria

Inclusion

  • Inclusion Criteria-
  • Clinic inclusion criteria:
  • Public sector facility
  • Primary care, outpatient clinic
  • Follows national guidelines for HIV counseling
  • Has dedicated HIV counselors
  • At least 10 patients receiving HIV counseling per week (based on pre-study data)
  • Follows national guidelines for lab monitoring (CD4 at diagnosis; VLs at 3 and 10 months on ART)
  • Is interested in participating, as indicated by "sign-off" from the head nurse / facility director
  • Individual participant inclusion criteria:
  • Adult (at least 18 years)
  • Received HIV post-test counselling or adherence counseling
  • Able to consent
  • Provides informed consent
  • Speaks one of the primary study languages: English, Zulu, Sotho, Tsonga
  • Receives care at the facility as evidence by having a clinical record there
  • Individual participant exclusion Criteria:
  • Require acute medical care that would be hindered by participation in the study
  • Determined by clinical staff not to be physically or emotionally able to initiate ART
  • Children (under 18 years).
  • Prisoners or other institutionalized persons.
  • Do not speak one of the primary study languages: English, Zulu, Sotho
  • Are not able to consent (e.g. intoxicated or of limited mental capacity)
  • Do not consent to participate in the study, including linkage to clinical records for follow-up

Exclusion

    Key Trial Info

    Start Date :

    April 1 2026

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    January 1 2029

    Estimated Enrollment :

    880 Patients enrolled

    Trial Details

    Trial ID

    NCT07199634

    Start Date

    April 1 2026

    End Date

    January 1 2029

    Last Update

    September 30 2025

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.